Irbesartan And Hydrochlorothiazide recalls

Irbesartan And Hydrochlorothiazide products have been recalled 6 times, most recently on 6 Feb 2019. The recalling company is usually Prinston Pharmaceutical. The most common reason is nitrosamine impurity.

Total recalls6since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 6 Feb 2019

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 4 67%Class III 2 33%

Why irbesartan and hydrochlorothiazide is recalled

Product types

By year

All irbesartan and hydrochlorothiazide recalls, newest first

6 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIIrbesartan and HydrochlorothiazideTablets, USP 150/12.5 mg recalledIrbesartan And HydrochlorothiazidePrinston PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIIrbesartan and Hydrochlorothiazide Tablets, USP 150/12.5 mg Rx Only recalledIrbesartan And HydrochlorothiazidePrinston PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIIrbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg recalledIrbesartan And HydrochlorothiazidePrinston PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIIrbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg recalledIrbesartan And HydrochlorothiazidePrinston PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIIIrbesartan and Hydrochlorothiazide Tablets, USP, 300/12.5 mg recalledIrbesartan And HydrochlorothiazidePrinston PharmaceuticalOtherNationwide
DrugCLASS IIIIrbesartan and Hydrochlorothiazide tablets USP 150 mg/ 5 mg recalledIrbesartan And HydrochlorothiazideTeva Pharmaceutical IndustriesOtherNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.